New cancer drug trial cut short after early testing
NCT ID NCT06488716
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 34 times
Summary
This early-stage study tested a new drug called RO7759065, alone or with another drug (atezolizumab), in 12 people with advanced solid tumors that could not be cured. The main goals were to check safety and how the drug moves through the body. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOUR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
British Columbia Cancer Agency
Vancouver, British Columbia, V5Z 4R2, Canada
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Clinica Universidad de Navarra-Madrid
Madrid, 28027, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2MR, Canada
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
Sir Mortimer B Davis Jewish General Hospital-3755 Cote Sainte-Catherine
Montreal, Quebec, H3T 1E2, Canada
-
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
Tennesse Oncology - NASH - SCRI - PPDS
Chattanooga, Tennessee, 37404-1130, United States
-
University of Colorado
Aurora, Colorado, 80045-2517, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.